These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28847068)

  • 21. The importance of censoring in competing risks analysis of the subdistribution hazard.
    Donoghoe MW; Gebski V
    BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential trials in the context of competing risks: Concepts and case study, with R and SAS code.
    Baayen C; Volteau C; Flamant C; Blanche P
    Stat Med; 2019 Aug; 38(19):3682-3702. PubMed ID: 31099906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competing risk bias in Kaplan-Meier risk estimates can be corrected.
    van Walraven C; Hawken S
    J Clin Epidemiol; 2016 Feb; 70():101-5. PubMed ID: 26327491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical issues in the analysis of adverse events in time-to-event data.
    Allignol A; Beyersmann J; Schmoor C
    Pharm Stat; 2016 Jul; 15(4):297-305. PubMed ID: 26929180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accounting for death as a competing risk in cancer-associated thrombosis studies.
    Campigotto F; Neuberg D; Zwicker JI
    Thromb Res; 2012 Apr; 129 Suppl 1():S85-7. PubMed ID: 22682141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A note on competing risks in survival data analysis.
    Satagopan JM; Ben-Porat L; Berwick M; Robson M; Kutler D; Auerbach AD
    Br J Cancer; 2004 Oct; 91(7):1229-35. PubMed ID: 15305188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model selection in competing risks regression.
    Kuk D; Varadhan R
    Stat Med; 2013 Aug; 32(18):3077-88. PubMed ID: 23436643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.
    Latouche A; Allignol A; Beyersmann J; Labopin M; Fine JP
    J Clin Epidemiol; 2013 Jun; 66(6):648-53. PubMed ID: 23415868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analyses of cumulative incidence functions via non-parametric multiple imputation.
    Ruan PK; Gray RJ
    Stat Med; 2008 Nov; 27(27):5709-24. PubMed ID: 18712779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use and interpretation of competing risks regression models.
    Dignam JJ; Zhang Q; Kocherginsky M
    Clin Cancer Res; 2012 Apr; 18(8):2301-8. PubMed ID: 22282466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Planning and analyzing clinical trials with competing risks: Recommendations for choosing appropriate statistical methodology.
    Poythress JC; Lee MY; Young J
    Pharm Stat; 2020 Jan; 19(1):4-21. PubMed ID: 31625290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions.
    Bonofiglio F; Beyersmann J; Schumacher M; Koller M; Schwarzer G
    Res Synth Methods; 2016 Sep; 7(3):282-93. PubMed ID: 26387882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vertical modelling: Analysis of competing risks data with missing causes of failure.
    Nicolaie MA; van Houwelingen HC; Putter H
    Stat Methods Med Res; 2015 Dec; 24(6):891-908. PubMed ID: 22179822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations for analysis of time-to-event outcomes subject to competing risks in veterinary clinical studies.
    Oyama MA; Shaw PA; Ellenberg SS
    J Vet Cardiol; 2018 Jun; 20(3):143-153. PubMed ID: 29680637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing points-based risk-scoring systems in the presence of competing risks.
    Austin PC; Lee DS; D'Agostino RB; Fine JP
    Stat Med; 2016 Sep; 35(22):4056-72. PubMed ID: 27197622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competing risks in epidemiology: possibilities and pitfalls.
    Andersen PK; Geskus RB; de Witte T; Putter H
    Int J Epidemiol; 2012 Jun; 41(3):861-70. PubMed ID: 22253319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.
    Arbetter DF; Jain P; Yee MK; Michalak N; Hernandez AF; Hull RD; Goldhaber SZ; Harrington RA; Gold A; Cohen AT; Gibson CM
    Pharm Stat; 2017 Nov; 16(6):445-450. PubMed ID: 28840662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis.
    Fonseca I; Teixeira L; Malheiro J; Martins LS; Dias L; Castro Henriques A; Mendonça D
    Transpl Int; 2015 Jun; 28(6):738-50. PubMed ID: 25689397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hierarchical likelihood inference on clustered competing risks data.
    Christian NJ; Ha ID; Jeong JH
    Stat Med; 2016 Jan; 35(2):251-67. PubMed ID: 26278918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.